Synovus Financial’s Genomic Health, Inc. GHDX Stock Holding History

Synovus Financial’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-92	Closed	-$6K	–	1620
2019 Q3	$6K	Hold	92	–	–	﹤0.01%	1277
2019 Q2	$5K	Hold	92	–	–	﹤0.01%	1235
2019 Q1	$6K	Hold	92	–	–	﹤0.01%	1209
2018 Q4	$6K	Hold	92	–	–	﹤0.01%	1188
2018 Q3	$6K	Buy	+92	New	+$5.38K	﹤0.01%	1220

Synovus Financial's GHDX Position: Q4 2019 in Review

Synovus Financial sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 92 shares — an estimated $6K sold.

Synovus Financial first reported a position in GHDX in Q3 2018 and held it in 5 quarters. The position peaked at $6K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Synovus Financial reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Synovus Financial sold 92 Genomic Health, Inc. shares in Q4 2019, an estimated $6K.
Synovus Financial first reported a position in Genomic Health, Inc. in Q3 2018 and held it in 5 quarters.
Synovus Financial's Genomic Health, Inc. position peaked at $6K in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Synovus Financial's 13F filing for Q4 2019, filed 6 Feb 2020.